Connection
Search Results to
This is a "connection" page, showing the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.
| Property | Value |
|
has major subject area list
|
Dermatologic Agents; Dermatomyositis; Immunosuppressive Agents; Infliximab
|
|
information resource reference
|
Schiffenbauer A, Garg M, Castro C, Pokrovnichka A, Joe G, Shrader J, Cabalar IV, Faghihi-Kashani S, Harris-Love MO, Plotz PH, Miller FW, Gourley M. A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis. Semin Arthritis Rheum. 2018 06; 47(6):858-864.
|
|
label
|
A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis.
|